Penicillin injection recall could jeopardize syphilis control efforts
A recent withdrawal of injectable penicillin has caused concern among public health authorities, healthcare practitioners, and community groups devoted to managing sexually transmitted diseases. The withdrawal, impacting a particular batch of injectable penicillin primarily used to treat syphilis, might hamper the recent advances in fighting an illness that has alarmingly re-emerged in recent years.Penicillin G benzathine, commonly known by the brand name Bicillin L-A, is the gold-standard treatment for syphilis, particularly in pregnant individuals, where it plays a critical role in preventing congenital syphilis—a condition passed from mother to baby during pregnancy. The safety and effectiveness of this injectable antibiotic…
